Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea ; volume:25 ; number:1 ; day:20 ; month:1 ; year:2024 ; pages:1-11 ; date:12.2024
BMC musculoskeletal disorders ; 25, Heft 1 (20.1.2024), 1-11, 12.2024
- Urheber
-
Cha, Seungju
Sohn, Minjeong
Yang, Hyowon
Yeh, Eric J.
Baek, Ki-Hyun
Ha, Jeonghoon
Ku, Hyemin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-024-07185-8
- URN
-
urn:nbn:de:101:1-2024033122050701469634
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cha, Seungju
- Sohn, Minjeong
- Yang, Hyowon
- Yeh, Eric J.
- Baek, Ki-Hyun
- Ha, Jeonghoon
- Ku, Hyemin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review
Knowledge gap in a cross section of Irish general practitioners prescribing denosumab for osteoporosis
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis
Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab in osteoporosis management for diabetes patients: insights from clinical trials and explorations for dual benefit
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review
Knowledge gap in a cross section of Irish general practitioners prescribing denosumab for osteoporosis
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis
Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab in osteoporosis management for diabetes patients: insights from clinical trials and explorations for dual benefit
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review
Knowledge gap in a cross section of Irish general practitioners prescribing denosumab for osteoporosis
A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis
Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis
Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study
Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates